[Remote] Clinical Business Analyst at Clairo

Costa Rica

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Clinical Trials, BiotechnologyIndustries

Requirements

Bachelor’s degree in a related field or equivalent experience
Minimum 2 years’ experience in medical writing, project management, or business analysis in a global clinical trial environment
Proven expertise in developing software configuration specifications
Strong proficiency in documentation, problem-solving, and analytical skills
Demonstrated ability to work independently and collaboratively across teams

Responsibilities

Gather and document client configuration requirements from scientific, project, and stakeholder teams
Create and maintain client configuration specifications and support validation, UAT testing, installation, and deployment
Collaborate with product management to define enhancements and attend training on new system features
Support Clinical Project Management and Operations by attending study kickoffs, training end users, and identifying operational efficiencies
Present to senior leadership and clients; oversee release schedules and monitor delivery metrics for continuous improvement
Supervise team members by setting expectations, coaching, conducting performance evaluations, and supporting career development

Skills

business analysis

requirements gathering

documentation

UAT testing

software configuration

project management

clinical trials

medical writing

problem-solving

analytical skills

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free